Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
FDA classifies Bacillus tests
You may also be interested in...
Regulatory News In Brief
Dermal filler advisory panel
Regulatory News In Brief
Dermal filler advisory panel
Innovation Efforts Offer A Way To Change FDA's Views On Risk, Industry Says
FDA should put more emphasis on product benefits and patients' willingness to take on risk in pre-market reviews of particularly innovative devices, industry participants argued during an agency workshop last week.